SANA - Sana gets FDA clearance to initiate clinical study for SC262
2024-01-05 09:40:02 ET
More on Sana Biotechnology
- Sana Biotechnology: Still Early Days, Lots Of Dilution Ahead
- Biggest stock movers today: Palantir, Peloton, Medical Properties Trust, and more
- Sana publishes Phase 1 data for CLL therapy in medical journal
- Seeking Alpha’s Quant Rating on Sana Biotechnology
- Historical earnings data for Sana Biotechnology
For further details see:
Sana gets FDA clearance to initiate clinical study for SC262